Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Synergistic Enteral Regimen for Treatment of the Gangliosidoses (Syner-G)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02030015
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:13.331774+00:00
Published At
2021-04-14T00:00:00+00:00
Record Updated At
2021-04-14
Results Posted At
2021-04-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["GM1 Gangliosidoses", "GM2 Gangliosidoses", "Tay-Sachs Disease", "Sandhoff Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-04-14"
protocolSection.identificationModule.nctId
"NCT02030015"
protocolSection.identificationModule.officialTitle
"Synergistic Enteral Regimen for Treatment of the Gangliosidoses (Syner-G)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-04-14"

Study condition terms

  • GM1 Gangliosidoses (protocolSection.conditionsModule.conditions)
  • GM2 Gangliosidoses (protocolSection.conditionsModule.conditions)
  • Tay-Sachs Disease (protocolSection.conditionsModule.conditions)
  • Sandhoff Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.